₨ 240,000
Tecentriq (atezolizumab) 1200 mg/20 mL solution for infusion is a cancer immunotherapy medication used to treat several types of cancer, including certain forms of lung, bladder, liver, and breast cancer. The medication works by stimulating the body's immune system to identify and attack cancer cells.
Key Information:
- Active Ingredient: Atezolizumab.
- Mechanism of Action: Atezolizumab is a monoclonal antibody that works as an immune checkpoint inhibitor. It binds to a protein called PD-L1, which is found on the surface of some cancer cells, preventing it from suppressing the immune system and allowing T-cells to attack the cancer more effectively.
- Administration: It is administered as an intravenous (IV) infusion by a qualified healthcare professional. The initial infusion typically takes about 60 minutes, and subsequent infusions may be shorter, lasting around 30 minutes, if the first dose is well-tolerated. There is also a subcutaneous (under the skin) injection version available in some regions, which can reduce treatment time to minutes.
- Indications: Tecentriq is used to treat:
- Non-small cell lung cancer (NSCLC).
- Small cell lung cancer (SCLC).
- Hepatocellular carcinoma (a type of liver cancer).
- Metastatic urothelial carcinoma (bladder and urinary tract cancer).
- Metastatic triple-negative breast cancer (TNBC).
- Melanoma.
- Alveolar soft part sarcoma (ASPS).
- Side Effects: Common side effects can include fatigue, decreased appetite, nausea, cough, and shortness of breath. Serious side effects can occur due to the medicine causing the immune system to attack healthy organs, which may lead to inflammation in the lungs, liver, intestines, or other organs. Patients are monitored for these reactions during and after treatment.
Disclaimer: This information is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
₨ 10,000
